Learn / Conditions / Whole-body, fatigue and labels
Neuroplastic symptoms · Whole-body, fatigue and labels

Inflammation: the one word that hides two completely different things.

A hot, swollen joint and a slightly raised CRP are both called inflammation. One hurts. The other does not, and knowing the difference changes everything.

Karuna LabsUpdated 2026-10-146 min read
The short answer

'Inflammation' is one of the most common explanations people are given for pain, and one of the least precise. The ATNS Index of Neuroplastic Symptoms separates two kinds. Large-scale, visible inflammation (an infected wound, appendicitis, a rheumatoid joint, gout) damages tissue, activates sensory nerves and commonly causes pain. Small-scale, microscopic inflammation, the low-grade background activity measured roughly by blood tests like CRP and ESR, is widespread, slow, present in everyone to some degree, and does not trigger pain. The index says that if a person with pain has no organ or structural abnormality other than this low-grade inflammation, they should be assessed for neuroplastic symptoms: real pain produced by a sensitized nervous system. An approach exists that addresses them.

This page is about understanding the condition and the role the brain and nervous system can play in it. It is not a diagnosis. Your own clinicians know your case.

What 'inflammation' means

Inflammation is the body's response to injury, infection or anything it reads as an attack. The ATNS Index of Neuroplastic Symptoms draws a sharp line between two forms that are often lumped together.

Macro-inflammation is the visible kind. Chemicals and white blood cells flood a specific area, producing swelling, redness, heat, tenderness and loss of function. This kind of inflammation damages tissue, which stimulates sensory nerves, which tells the brain to produce pain.

Micro-inflammation is invisible, driven by signalling proteins called cytokines, and happens quietly in tissues throughout the body. It cannot be seen, is hard to measure, and is only roughly reflected by blood tests like C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR). Everyone has some. It rises and falls over months and years, not minutes. And here is the point the index makes firmly: it does not activate a danger signal and it does not cause pain.

The neuroplastic contribution

Neuroplastic symptoms are real symptoms generated by learned pathways in the brain and nervous system rather than by ongoing damage or disease in the body. That alarm can become sensitized, firing loudly in the absence of tissue damage. Such pain is not imaginary and not 'all in your head'. It is a learned state, and because the brain can change, it can be unlearned.

The ATNS index's position on inflammation follows directly from the two-kinds distinction. Macro-inflammation commonly causes pain and needs to be found and treated. Micro-inflammation does not cause pain. So if someone has pain, and the only abnormality anyone can find is a modestly raised CRP or ESR, or a general sense that they are 'inflamed', the index says they should be assessed for neuroplastic symptoms. The low-grade inflammation is not the explanation, and a sensitized nervous system very often is.

Why does this matter so much? Because 'you have inflammation' is a sentence that can quietly do harm:

None of this makes micro-inflammation unimportant for long-term health. It means the word on its own is not a diagnosis of why you hurt. Our explainer on the three types of pain sets out the categories that do explain it.

What the research shows

Research on low-grade inflammation and chronic pain mostly points the same way as the ATNS index, with one honest wrinkle. A large cross-sectional study of US adults in the national NHANES survey found that people with chronic pain had somewhat higher CRP on average, and the highest quarter of CRP levels was linked to roughly a third higher risk of chronic pain than the lowest. A snapshot like that cannot show which way the arrow points: pain, poor sleep and inactivity can all nudge CRP up.

A Mendelian randomization study tested cause and effect using genetic variants that raise CRP across a lifetime. It found no evidence that CRP causes spinal pain, multisite chronic pain or chronic widespread pain, and the authors suggested that the search for pain biomarkers should look beyond CRP.

Even in genuine inflammatory disease, inflammation explains only part of the pain. A study of 96 people with active rheumatoid arthritis found that inflammation markers explained pain better than lab tests of central sensitization, yet much of the variation in pain severity was not explained by measures of inflammation at all. A 2026 review of shared mechanisms across fibromyalgia, osteoarthritis and inflammatory arthritis concluded that pain in rheumatoid and psoriatic arthritis often fails to track inflammation, and that central sensitization contributes to persistent pain. If pain and inflammation do not fully line up even in inflammatory disease, a mildly raised CRP with no disease is a weak explanation. Our explainer on central sensitization goes deeper.

Signs the brain may be part of the picture

Try this today

Look for the five signs

Macro-inflammation has five classic signs: redness, heat, swelling, pain and loss of function. Take two minutes and examine the place that hurts most. Is it red compared with the other side? Warmer to the back of your hand? Visibly swollen? If the honest answer is 'it just hurts, and it looks and feels like the other side', that is useful information: the pain is less likely to be coming from inflamed tissue and more likely to be coming from a sensitized alarm. Then say to yourself, 'This hurts, and it is not damaged,' and take three slow breaths while you keep your attention gently on the spot.

A solution that addresses it

There is an approach that addresses the brain's contribution to pain: pain reprocessing. It starts with clear education about neuroplastic symptoms, uses somatic tracking to observe sensations with curiosity instead of alarm, reduces fear and threat (including the fear that your body is quietly burning), rebuilds activity in graded steps, invites emotional awareness and expression, and draws on acceptance and commitment skills. Trained clinicians deliver it, and it is increasingly available through digital programs.

Cindra is a daily AI companion built around these approaches, with daily check-ins, short practices and plain-language lessons, for people whose symptoms have a neuroplastic component. If 'inflammation' has been your only answer for too long, you can join the waitlist.

What to do next

  1. Ask your clinician a precise question: 'Is there a specific site of inflammation that explains my pain, or is this a general blood marker?' If there is a site, such as an inflamed joint, gut or tendon, treat it properly.
  2. If a raised CRP or ESR is persistent and unexplained, let your doctor investigate it on its own terms. Occasionally it points to an infection, an autoimmune disease or, rarely, a cancer, and that needs to be excluded.
  3. If no structural or organ abnormality is found beyond low-grade inflammation, ask whether your pain fits a neuroplastic pattern.
  4. If it might, start learning and practising. Our guide to hurt versus harm is the right first read.

See a doctor promptly for a hot, red, swollen joint or area, fever, unexplained weight loss, night sweats or a CRP that keeps rising.

Questions people ask

Does inflammation cause chronic pain?

Visible, local inflammation (a swollen joint, an infection) does cause pain. The low-grade, microscopic inflammation measured roughly by CRP and ESR does not, according to the ATNS Index of Neuroplastic Symptoms. If that low-grade inflammation is the only finding, the index recommends assessment for neuroplastic symptoms.

My CRP is slightly raised. Is that why I hurt?

Almost certainly not on its own. Everyone has some micro-inflammation, and it changes slowly over months. Studies find CRP runs slightly higher on average in people with chronic pain, but a large genetic study found no sign that CRP itself causes chronic pain. A persistently raised marker still deserves investigation for its own sake, but it is not an explanation for pain.

Will an anti-inflammatory diet fix my pain?

But if your pain is neuroplastic, diet is aiming at the wrong target, which is why so many people find it makes little difference to how they feel day to day.

References

  1. Association between C-reactive protein and chronic pain in US adults: A nationwide cross-sectional study. PMC11805396
  2. No evidence for causal effects of C-reactive protein (CRP) on chronic pain conditions: a Mendelian randomization study. PMID 39006441
  3. Contribution of inflammation markers and quantitative sensory testing (QST) indices of central sensitisation to rheumatoid arthritis pain. PMC11460083
  4. Central Sensitization and Nociplastic Pain: Shared Mechanisms in Fibromyalgia, Osteoarthritis, and Inflammatory Arthritis. 2026. PMID 41919065
Source: the definition and neuroplastic-contribution framing on this page summarise, in our own words, the entry “Inflammation” in the Index of Neuroplastic Symptoms (2026) published by the Association for the Treatment of Neuroplastic Symptoms (ATNS, neuroplastic.org). The research summary cites the PubMed records listed above.
Cindra

A daily companion for the hard days and the ordinary ones.

Cindra is an AI companion from Karuna Labs built around acceptance and commitment therapy and the science of neuroplastic symptoms. It checks in with you each day, helps you notice what your symptoms are pulling you away from, and nudges you back toward the things that matter. Cindra is invite-only while we build it with early members.

Join the waitlist

This article is for general education and is not medical advice, and it does not diagnose or treat any condition. Persistent symptoms deserve a proper medical assessment to rule out disease or injury before a neuroplastic explanation is considered. If your symptoms are new, changing, or come with red-flag signs such as fever, unexplained weight loss, numbness or weakness, chest pain, or loss of bladder or bowel control, see a clinician promptly.